Name
osaühing Riolani
Registry code
10515521
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
22.01.1999 (25)
Financial year
01.01-31.12
Capital
2 600.00 €
Activity
86211 - Provision of general medical treatment
15 750 €
-24 440 €
-155%
1 419 €
(estimate is approximate)
90 782 €
1
Submitted
No tax arrears
-27%
-26%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Merike Ausmees 14.01.1955 (69) | 100% - 2 600.00 EUR | Board member | Direct ownership | Founder |
| Omanikukonto: Kristo Ausmees 19.01.1978 (46) | - | - | - | Founder |
| 2019 12.06.2020 | 2020 17.06.2021 | 2021 28.06.2022 | 2022 19.06.2023 | 2023 19.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 232 267 € | 267 057 € | 110 821 € | 3 321 € | 15 750 € |
| Net profit (loss) for the period | 65 404 € | 73 106 € | 7 379 € | -16 716 € | -24 440 € |
| Profit Margin | 28% | 27% | 7% | -503% | -155% |
| Current Assets | 211 244 € | 246 798 € | 204 815 € | 149 691 € | 82 206 € |
| Fixed Assets | 15 132 € | 14 365 € | 13 608 € | 12 636 € | 11 662 € |
| Total Assets | 226 376 € | 261 163 € | 218 423 € | 162 327 € | 93 868 € |
| Current Liabilities | 9 923 € | 11 604 € | 1 485 € | 2 105 € | 3 086 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 216 453 € | 249 559 € | 216 938 € | 160 222 € | 90 782 € |
| Employees | 2 | 3 | 2 | 0 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 3 878.82 € | 3 752.4 € | 1 |
| 2023 Q4 | - | 1 912.52 € | 1 773.22 € | 2 |
| 2023 Q3 | - | 13 348.65 € | 5 444.12 € | 1 |
| 2023 Q2 | - | 2 018.52 € | 1 880.82 € | 2 |
| 2023 Q1 | - | 2 230.52 € | 2 079.22 € | 2 |
| 2022 Q4 | - | 428.52 € | 266.82 € | 2 |
| 2022 Q3 | - | 11 043.01 € | 4 080.99 € | - |
| 2022 Q2 | - | 428.52 € | 266.82 € | 1 |
| 2022 Q1 | - | 1 636.92 € | 1 476.66 € | 1 |
| 2021 Q4 | - | 428.52 € | 266.82 € | 1 |
| 2021 Q3 | - | 12 244.1 € | 4 960.62 € | - |
| 2021 Q2 | - | 16 554.43 € | 17 046.96 € | 1 |
| 2021 Q1 | - | 10 136.71 € | 10 382.32 € | 5 |
| 2020 Q4 | - | 9 859.32 € | 10 127.97 € | 4 |
| 2020 Q3 | - | 21 473.76 € | 13 398.3 € | 4 |
| 2020 Q2 | - | 9 337.82 € | 9 623.94 € | 4 |
| 2020 Q1 | - | 8 640.84 € | 8 824.74 € | 3 |
